The Protective Effect of Polygonum cuspidatum (PCE) Aqueous Extract in a Dry Eye Model
Bongkyun Park, Ik Soo Lee, Soo-Wang Hyun, Kyuhyung Jo, Tae Gu Lee, Jin Sook Kim, Chan-Sik Kim, Bongkyun Park, Ik Soo Lee, Soo-Wang Hyun, Kyuhyung Jo, Tae Gu Lee, Jin Sook Kim, Chan-Sik Kim
Abstract
Dry eyes are caused by highly increased osmolarity of tear film, inflammation, and apoptosis of the ocular surface. In this study, we investigated the effect of Polygonum cuspidatum (PCE) aqueous extract in in vivo and in vitro dry eye models. Dry eye was induced by excision of the lacrimal gland and hyperosmotic media. In vivo, oral administration of PCE in exorbital lacrimal gland-excised rats recovered tear volume and Mucin4 (MUC4) expression by inhibiting corneal irregularity and expression of inflammatory cytokines. In vitro, hyperosmotic media induced human corneal epithelial cell (HCEC) cytotoxicity though increased inflammation, apoptosis, and oxidative stress. PCE treatment significantly inhibited expression of cyclooxygenase-2 and inflammatory cytokines (interleukin-6 and tumor necrosis factor-α), and activation of NF-κB p65 in hyperosmolar stress-induced HCECs. Hyperosmolarity-induced increase in Bcl-2-associated X protein (BAX) expression and activation of cleaved poly (ADP-ribose) polymerase and caspase 3 were attenuated in a concentration-dependent manner by PCE. PCE treatment restored anti-oxidative proteins such as heme oxygenase-1 (HO-1), superoxide dismutase-1 (SOD-1), and glutathione peroxidase (GPx) in hyperosmolar stress-induced HCECs. These data demonstrate that PCE prevents adverse changes in the ocular surface and tear fluid through inhibition of hyperosmolar stress-induced inflammation, apoptosis, and oxidation, suggesting that PCE may have the potential to preserve eye health.
Keywords: Mucin4; Polygonum cuspidatum; apoptosis; dry eye; exorbital lacrimal gland-excised; human corneal epithelial cells; hyperosmolar stress; inflammation; matrix metallopeptidase 9 (MMP9); oxidative stress.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
- Stevenson W., Chauhan S.K., Dana R. Dry eye disease: An immune-mediated ocular surface disorder. Arch. Ophthalmol. 2012;130:90–100. doi: 10.1001/archophthalmol.2011.364.
- Deng R., Su Z., Hua X., Zhang Z., Li D.-Q., Pflugfelder S.C. Osmoprotectants suppress the production and activity of matrix metalloproteinases induced by hyperosmolarity in primary human corneal epithelial cells. Mol. Vis. 2014;20:1243.
- Lemp M.A. Advances in understanding and managing dry eye disease. Am. J. Ophthalmol. 2008;146:350–356. doi: 10.1016/j.ajo.2008.05.016.
- Nakamura T., Hata Y., Nagata M., Yokoi N., Yamaguchi S., Kaku T., Kinoshita S. JBP485 promotes tear and mucin secretion in ocular surface epithelia. Sci. Rep. 2015;5:10248. doi: 10.1038/srep10248.
- Green-Church K.B., Butovich I., Willcox M., Borchman D., Paulsen F., Barabino S., Glasgow B.J. The international workshop on meibomian gland dysfunction: Report of the subcommittee on tear film lipids and lipid–protein interactions in health and disease. Investig. Ophthalmol. Vis. Sci. 2011;52:1979–1993. doi: 10.1167/iovs.10-6997d.
- Bhavsar A.S., Bhavsar S.G., Jain S.M. A review on recent advances in dry eye: Pathogenesis and management. Oman J. Ophthalmol. 2011;4:50–56.
- Li D.-Q., Luo L., Chen Z., Kim H.-S., Song X.J., Pflugfelder S.C. JNK and ERK MAP kinases mediate induction of IL-1β, TNF-α and IL-8 following hyperosmolar stress in human limbal epithelial cells. Exp. Eye Res. 2006;82:588–596. doi: 10.1016/j.exer.2005.08.019.
- De Paiva C.S., Corrales R.M., Villarreal A.L., Farley W.J., Li D.-Q., Stern M.E., Pflugfelder S.C. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp. Eye Res. 2006;83:526–535. doi: 10.1016/j.exer.2006.02.004.
- Luo L., Li D.-Q., Pflugfelder S.C. Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways. Cornea. 2007;26:452–460. doi: 10.1097/ICO.0b013e318030d259.
- Li D., Pflugfelder S. Matrix Metalloproteinases in Corneal Inflammation. Ocul. Surf. 2005;3:S198–S202. doi: 10.1016/S1542-0124(12)70255-0.
- Li D.-Q., Chen Z., Song X.J., Luo L., Pflugfelder S.C. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. Investig. Ophthalmol. Vis. Sci. 2004;45:4302–4311. doi: 10.1167/iovs.04-0299.
- Melnikov S., Mayan H., Uchida S., Holtzman E.J., Farfel Z. Cyclosporine metabolic side effects: Association with the WNK4 system. Eur. J. Clin. Investig. 2011;41:1113–1120. doi: 10.1111/j.1365-2362.2011.02517.x.
- Hornbeak D.M., Thorne J.E. Immunosuppressive therapy for eye diseases: Effectiveness, safety, side effects and their prevention. Taiwan J. Ophthalmol. 2015;5:156–163. doi: 10.1016/j.tjo.2015.03.004.
- Perry H.D., Solomon R., Donnenfeld E.D., Perry A.R., Wittpenn J.R., Greenman H.E., Savage H.E. Evaluation of topical cyclosporine for the treatment of dry eye disease. Arch. Ophthalmol. 2008;126:1046–1050. doi: 10.1001/archopht.126.8.1046.
- Dastjerdi M.H., Hamrah P., Dana R. High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen. Cornea. 2009;28:1091. doi: 10.1097/ICO.0b013e3181a16472.
- Zhang H., Li C., Kwok S.-T., Zhang Q.-W., Chan S.-W. A review of the pharmacological effects of the dried root of Polygonum cuspidatum (Hu Zhang) and its constituents. Evid.-Based Complement. Altern. Med. 2013;2013 doi: 10.1155/2013/208349.
- Zhu Y.-P., Woerdenbag H.J. Traditional Chinese herbal medicine. Pharm. World Sci. 1995;17:103–112. doi: 10.1007/BF01872386.
- Zhang H., Zhang Q.-W., Wang L., Zhang X.-Q., Ye W.-C., Wang Y.-T. Two new anthraquinone malonylglucosides from Polygonum cuspidatum. Nat. Prod. Res. 2012;26:1323–1327. doi: 10.1080/14786419.2011.578072.
- Kim Y.-S., Hwang C.-S., Shin D.-H. Volatile constituents from the leaves of Polygonum cuspidatum S. et Z. and their anti-bacterial activities. Food Microbiol. 2005;22:139–144. doi: 10.1016/j.fm.2004.01.016.
- Bralley E.E., Greenspan P., Hargrove J.L., Wicker L., Hartle D.K. Topical anti-inflammatory activity of Polygonum cuspidatum extract in the TPA model of mouse ear inflammation. J. Inflamm. 2008;5:1. doi: 10.1186/1476-9255-5-1.
- Hsu C.-Y., Chan Y.-P., Chang J. Antioxidant activity of extract from Polygonum cuspidatum. Biol. Res. 2007;40:13–21. doi: 10.4067/S0716-97602007000100002.
- Wu X.-B., Luo X.-Q., Gu S.-Y., Xu J.-H. The effects of Polygonum cuspidatum extract on wound healing in rats. J. Ethnopharmacol. 2012;141:934–937. doi: 10.1016/j.jep.2012.03.040.
- Chang J.-S., Liu H.-W., Wang K.-C., Chen M.-C., Chiang L.-C., Hua Y.-C., Lin C.-C. Ethanol extract of Polygonum cuspidatum inhibits hepatitis B virus in a stable HBV-producing cell line. Antivir. Res. 2005;66:29–34. doi: 10.1016/j.antiviral.2004.12.006.
- Lv W.-F., Ding M.-Y., Zheng R. Isolation and quantitation of amygdalin in Apricot-kernel and Prunus Tomentosa Thunb. by HPLC with solid-phase extraction. J. Chromatogr. Sci. 2005;43:383–387. doi: 10.1093/chromsci/43.7.383.
- Kim C.-S., Jo K., Lee I.-S., Kim J. Topical application of apricot kernel extract improves dry eye symptoms in a unilateral exorbital lacrimal gland excision mouse. Nutrients. 2016;8:750. doi: 10.3390/nu8110750.
- Yoon K.-C., Ahn K.-Y., Choi W., Li Z., Choi J.-S., Lee S.-H., Park S.-H. Tear production and ocular surface changes in experimental dry eye after elimination of desiccating stress. Investig. Ophthalmol. Vis. Sci. 2011;52:7267–7273. doi: 10.1167/iovs.11-7231.
- Sohn E.J., Kim C.-S., Kim Y.S., Jung D.H., Jang D.S., Lee Y.M., Kim J.S. Effects of magnolol (5, 5′-diallyl-2, 2′-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto–Kakizaki rats. Life Sci. 2007;80:468–475. doi: 10.1016/j.lfs.2006.09.037.
- Corrales R.M., Narayanan S., Fernández I., Mayo A., Galarreta D.J., Fuentes-Páez G., Chaves F.J., Herreras J.M., Calonge M. Ocular mucin gene expression levels as biomarkers for the diagnosis of dry eye syndrome. Investig. Ophthalmol. Vis. Sci. 2011;52:8363–8369. doi: 10.1167/iovs.11-7655.
- Luo L., Li D.-Q., Corrales R.M., Pflugfelder S.C. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens. 2005;31:186–193. doi: 10.1097/01.ICL.0000162759.79740.46.
- Khandekar N., Willcox M.D., Shih S., Simmons P., Vehige J., Garrett Q. Decrease in hyperosmotic stress–induced corneal epithelial cell apoptosis by l-carnitine. Mol. Vis. 2013;19:1945–1956.
- Bell L.M., Leong M.L., Kim B., Wang E., Park J., Hemmings B.A., Firestone G.L. Hyperosmotic stress stimulates promoter activity and regulates cellular utilization of the serum and glucocorticoid inducible protein kinase (Sgk) by a p38/MAPK dependent pathway. J. Biol. Chem. 2000 doi: 10.1074/jbc.M002076200.
- Gipson I.K. The ocular surface: The challenge to enable and protect vision: The Friedenwald lecture. Investig. Ophthalmol. Vis. Sci. 2007;48:4391–4398. doi: 10.1167/iovs.07-0770.
- Gipson I.K., Argueso P., Beuerman R., Bonini S., Butovich I., Dana R., Dartt D., Gamache D., Ham B., Jumblatt M. Research in dry eye: Report of the Research Subcommittee of the International Dry Eye WorkShop (2007) Ocul. Surf. 2007;5:179–193.
- Kurose M., Meng I.D. Dry eye modifies the thermal and menthol responses in rat corneal primary afferent cool cells. J. Neurophysiol. 2013;110:495–504. doi: 10.1152/jn.00222.2013.
- Meng I.D., Barton S.T., Mecum N.E., Kurose M. Corneal sensitivity following lacrimal gland excision in the rat. Investig. Ophthalmol. Vis. Sci. 2015;56:3347–3354. doi: 10.1167/iovs.15-16717.
- Stevenson W., Chen Y., Lee S.-M., Lee H.S., Hua J., Dohlman T., Shiang T., Dana R. Extraorbital lacrimal gland excision: A reproducible model of severe aqueous tear-deficient dry eye disease. Cornea. 2014;33:1336–1341. doi: 10.1097/ICO.0000000000000264.
- Pflugfelder S.C. Antiinflammatory Therapy for Dry Eye. Elsevier; Amsterdam, The Netherlands: 2004.
- McCollum C.J., Foulks G.N., Bodner B., Shepard J., Daniels K., Gross V., Kelly L., Cavanagh H.D. Rapid assay of lactoferrin in keratoconjunctivitis sicca. Cornea. 1994;13:505–508. doi: 10.1097/00003226-199413060-00007.
- Solomon A., Dursun D., Liu Z., Xie Y., Macri A., Pflugfelder S.C. Pro-and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Investig. Ophthalmol. Vis. Sci. 2001;42:2283–2292.
- Afonso A.A., Sobrin L., Monroy D.C., Selzer M., Lokeshwar B., Pflugfelder S.C. Tear fluid gelatinase B activity correlates with IL-1α concentration and fluorescein clearance in ocular rosacea. Investig. Ophthalmol. Vis. Sci. 1999;40:2506–2512.
- Chotikavanich S., de Paiva C.S., Chen J.J., Bian F., Farley W.J., Pflugfelder S.C. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Investig. Ophthalmol. Vis. Sci. 2009;50:3203–3209. doi: 10.1167/iovs.08-2476.
- Pflugfelder S.C., Farley W., Luo L., Chen L.Z., de Paiva C.S., Olmos L.C., Li D.-Q., Fini M.E. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am. J. Pathol. 2005;166:61–71. doi: 10.1016/S0002-9440(10)62232-8.
- Kimura K., Teranishi S., Fukuda K., Kawamoto K., Nishida T. Delayed disruption of barrier function in cultured human corneal epithelial cells induced by tumor necrosis factor-α in a manner dependent on NF-κB. Investig. Ophthalmol. Vis. Sci. 2008;49:565–571. doi: 10.1167/iovs.07-0419.
- Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 2001;17:463–516. doi: 10.1146/annurev.cellbio.17.1.463.
- Tsubota K., Yokoi N., Shimazaki J., Watanabe H., Dogru M., Yamada M., Kinoshita S., Kim H.-M., Tchah H.-W., Hyon J.Y. New perspectives on dry eye definition and diagnosis: A consensus report by the Asia Dry Eye Society. Ocul. Surf. 2017;15:65–76. doi: 10.1016/j.jtos.2016.09.003.
- Pflugfelder S.C., Bian F., De Paiva C. Matrix metalloproteinase-9 in the pathophysiology and diagnosis of dry eye syndrome. Metalloproteinases Med. 2017;4:37–46. doi: 10.2147/MNM.S107246.
- Gipson I.K., Hori Y., Argüeso P. Character of ocular surface mucins and their alteration in dry eye disease. Ocul. Surf. 2004;2:131–148. doi: 10.1016/S1542-0124(12)70149-0.
- Kirschweng B., Tilinger D.M., Hégely B., Samu G., Tátraaljai D., Földes E., Pukánszky B. Melt stabilization of PE with natural antioxidants: Comparison of rutin and quercetin. Eur. Polym. J. 2018;103:228–237. doi: 10.1016/j.eurpolymj.2018.04.016.
- de Queiroz K.B., Pereira T.d.S.F., Araújo M.S.S., Gomez R.S., Coimbra R.S. Resveratrol Acts Anti-Inflammatory and Neuroprotective in an Infant Rat Model of Pneumococcal Meningitis by Modulating the Hippocampal miRNome. Mol. Neurobiol. 2018:1–16. doi: 10.1007/s12035-018-1037-5.
- Zhu X., Huang F., Xiang X., Fan M., Chen T. Evaluation of the potential of chicoric acid as a natural food antioxidant. Exp. Ther. Med. 2018;16:3651–3657. doi: 10.3892/etm.2018.6596.
- Romero-Pérez A.I., Ibern-Gómez M., Lamuela-Raventós R.M., de la Torre-Boronat M.C. Piceid, the major resveratrol derivative in grape juices. J. Agric. Food Chem. 1999;47:1533–1536. doi: 10.1021/jf981024g.
- Li X.-H., Gong X., Zhang L., Jiang R., Li H.-Z., Wu M.-J., Wan J.-Y. Protective effects of polydatin on septic lung injury in mice via upregulation of HO-1. Mediat. Inflamm. 2013;2013 doi: 10.1155/2013/354087.
- Indraccolo U., Barbieri F. Effect of palmitoylethanolamide–polydatin combination on chronic pelvic pain associated with endometriosis: Preliminary observations. Eur. J. Obstet. Gynecol. Reprod. Biol. 2010;150:76–79. doi: 10.1016/j.ejogrb.2010.01.008.
Source: PubMed